ORIG3N, an innovative biotech company that creating the world’s largest blood cell repository for induced pluripotent stem cell (iPS cell / iPSC) production. When James Lovgren, Chief Business Officer of ORIG3N, and I met at the World Stem Cell Summit, we intended to explore potential collaborations and synergy between our companies. Instead we had an inspired conversation about the global importance of iPS cells, stem cell market dynamics, and the importance of social platforms to the stem cell community.

I was so inspired by ORIG3N’s vision that I took advantage of the opportunity to interview Mr. Lovgren. [Read more…]